Oligonucleotide Synthesis Market : A Latest Research Report To Share Market Insights And Dynamics Forecast 2017 - 2025

Transparency Market Research (TMR) observes that the global oligonucleotide synthesis market has a highly competitive vendor landscape. Key players such as Thermo Fisher Scientific, DNA Technologies, GE Healthcare, BioAutomation, and Applied Biosystems are operating in the global oligonucleotide synthesis market. The stiff competition in the market is resulting in a high level of competition in the market, which is likely to increase treat for entrants in the market. In order to account for a substantial share in the global market and attract customers, the key players are cutting down prices.

According to the report by Transparency Market Research, the oligonucleotide synthesis market stood at US$1.65 bn in 2016 and is projected to reach a value of US$4.189 bn by the end of 2025. The market is likely to expand with a stellar CAGR of 11.2% over the forecast period from 2017 and 2025.

Based on the type, the synthesis oligonucleotides segment is expected to register the highest growth in the coming future owing to the high preference of pharmaceutical, research and diagnostics in the biotechnology sector. Based on the end user, the research institute segment is accounting for leading share over the forecast period. Based on the region, North America dominated the global oligonucleotides synthesis market and likely to dominate the market over the forecast period. However, Asia Pacific is likely to witness growth by clocking a healthy CAGR of 12.5% between 2017 and 2025. Of these, China is a major driver for growth in the region on the back of growing adoption from home to numerous small companies.

⦿ Growing Adoption of Genetic Testing to Propel Market Growth

The oligonucleotide synthesis market is gaining traction due to the declining cost of sequencing which is resulting in the customized nucleotides for the desired sequence across research and drug development. Additionally, the growing adoption of the oligonucleotide from genetic testing and forensic applications across various life science industries is propelling the growth of the global oligonucleotide synthesis market.

Oligonucleotide synthesis has a key role in several ongoing genetic research studies. Rising investments in genetic research are boosting demand for custom synthesis. The oligonucleotide synthesis is used for the manufacture of different classes of oligos such as decoys, immunostimulatory, aptamers, antisense, miRNA, and siRNA. Widening application of the oligonucleotide synthesis is propelling the growth of the global oligonucleotide synthesis market.

Request a PDF Brochure For Oligonucleotide Synthesis Market @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11804

⦿ Growing Approvals for Pipeline Drugs to Propel Market Growth

The largest share of the oligonucleotides is used across the phase clinical trials for targeting various diseases such as cancer, muscle dystrophies, cardiovascular diseases, and ocular disorders. Growing regulatory approvals on the multiple therapies especially based on the oligonucleotide are expected to drive the growth of the global oligonucleotide synthesis market.

Marketing focus and adoption of advanced strategies, which include enhancing direct selling, and distributors in specific countries especially developing countries. Additionally, benefits of the oligonucleotides and growing its synthesis are propelling the growth of the global oligonucleotides synthesis market.

This information is encompassed in the report by TMR, titled, “Oligonucleotide Synthesis Market (Product – Reagents & Consumables, Equipment, and Synthesized Oligonucleotides (DNA Oligonucleotides and RNA Oligonucleotides); Application – Research (Polymerase Chain Reaction and Next Generation Sequencing), Therapeutics (Antisense Oligonucleotides, and Nucleic Acid Aptamers), and Diagnostics; End User – Biotechnology & Pharmaceutical Companies, Research Institutes, and Diagnostic Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.”

⦿ For the study, the oligonucleotide synthesis market has been segmented as follows:

Product

TNF Inhibitors
Vitamin D Analogues or Combinations
Interleukin Blockers
Others
Therapy

Topical Therapeutic Drugs
Systemic Therapeutic Drugs
Combinations
Others
Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
Geography

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & Africa

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

This release was published on openPR.